James J Harding

42PUBLICATIONS

301CO-AUTHORS

Molecular targetsChemotherapyPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumours

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (42)

Sort by Publication Date:

|Jun 26, 2026

Molecular and Clinical Determinants of Targeted Therapy Treatment in Biliary Tract Cancer.

|Apr 16, 2026

BI 905711, a TRAILR2/CDH17 Bispecific Antibody, Alone or with Chemotherapy for Patients with Advanced Gastrointestinal Cancers: Phase I Study Findings.

|Feb 19, 2026

Shaping the Future of HER2-Directed Therapy in Biliary Tract Cancer.

Orla M Fitzpatrick, James J Harding

|Feb 10, 2026

How I Do It: Systemic Therapies for Primary Liver Cancers.

Tae-Hyung Kim, James J Harding, Victoria Chernyak

|Jan 07, 2026

IL10R Inhibition Induces Neutrophil Tumoricidal Activity.

Danny N Khalil, Ricardo Gomez, Amit Regev

|Nov 20, 2025

Delta-Like Ligand 3 Expression and Functional Imaging in Gastroenteropancreatic Neuroendocrine Neoplasms.

Rohit Thummalapalli, Salomon Tendler, Joanne F Chou

Pageof 7

Frequent Collaborators

17 joint publications

Ghassan K Abou-Alfa

13 joint publications

Eileen O'Reilly

10 joint publications

William R Jarnagin

Alice Wei

Kevin Soares

Wungki Park

Andrea Cercek

Henry Walch

Nikolaus Schultz

Mithat Gonen

Frequent Collaborators

17 joint publications

Ghassan K Abou-Alfa

13 joint publications

Eileen O'Reilly

10 joint publications

William R Jarnagin

9 joint publications

Alice Wei